openPR Logo
Press release

Rectal Cancer Market Professional Survey Report: Key Players are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG

06-15-2017 02:44 PM CET | Health & Medicine

Press release from: Transparency Market Research

Rectal Cancer Market Professional Survey Report: Key Players

Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal cancer, high-fat diet consumption and smoking. The most common type of rectal cancer is adenocarcinoma and comprises the majority of all the cases relating to rectal cancer. Other rare forms of rectal cancer are lymphoma, carcinoid, and sarcoma. Rectal bleeding, diarrhea, not being able to vacate the bowel completely, constipation, weight loss, bowel obstruction, small diameter tools, abdominal pain and weakness are some of the most common symptoms of rectal cancer. The various stages of rectal cancer are:

Stage I: Tumor is located in the first or second layer of the rectum wall but have not spread out of the rectum itself.
Stage II: Tumor spreads in the mesorectum.
Stage III: Tumor penetrates and spreads in the lymph nodes but not in order parts of the body.
Stage IV: Tumor spreads to different parts of the body, distant organs and tissues such as the lever or the lungs. It has spread outside the rectal region and stage IV is also known as metastatic rectal cancer stage.

Obtain Report Details @ http://www.transparencymarketresearch.com/rectal-cancer-market.html

Rectal Cancer Market Segmentation

Based on the diagnosis, the rectal cancer market can be segmented as follows:

Digital rectal examination (DRE)
Rigid proctoscopy
Laboratory tests, i.e., carcinoembryonic antigen (CEA) test, complete blood count etc.
Screening tests, i.e., stool DNA screening, flexible sigmoidoscopy, computed tomography (CT) colonography
Imaging tests, i.e., CT scanning of abdomen, endorectal ultrasonography, pelvic magnetic resonance imaging (MRI)

Before the treatment of a patient diagnosed with rectal cancer begins, three vital points have to be taken into consideration, i.e., the extent to which the tumor has spread, the involvement of lymph nodes and whether the tumor has spread to different parts of the body or not.

Based on the treatments involved, the rectal cancer market can be segmented as follows:

Surgery: Radical resection is the most important surgical treatment for rectal cancer. Others include transanal excision, transanal microsurgery, and endocavity radiotherapy.
Adjuvant medical therapy: Various adjuvant medical management therapies include intraoperative radiation therapy, adjuvant chemotherapy, chemoradiation therapy and radioembolization.
Pharmacotherapy:
Antineoplastic agents (for instance, fluorouracil, leucovorin, panitumumab etc.)
Vaccines (quadrivalent papillomavirus vaccine)

Based on geographical locations, the rectal cancer market can be segmented into four major segments: North America, Europe, Asia-Pacific and Rest of the World (ROW). Out of these four regions, North America dominates the rectal cancer market followed by Europe. The major driving reasons for the growth of rectal cancer market are constantly increasing geriatric population, growing awareness about malignant effects of cancer amongst individuals, and increasing unhealthy lifestyle practices such as smoking and consumption of high fat content food. Asia-Pacific is one of the most lucrative markets for the growth of rectal cancer market and it is continuously growing at a steady rate. The advantageous factors which will contribute towards the augmentation of rectal cancer market in Asia-Pacific are high population density including the geriatric population, rapidly increasing demand for technologically advanced therapeutic treatment, and major government support for improved healthcare infrastructures such as hospitals and clinics.

Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14954

Various pharmaceutical companies are constantly trying to come up with novel therapeutic drugs and surgeries for the treatment of rectal cancer. Some of the top major players operating in rectal cancer therapeutics market are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG, AstraZeneca PLC, Peregrine Pharmaceuticals, Inc., AbbVie, Inc., Nanobiotix, GenVec, Inc.,and many others.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rectal Cancer Market Professional Survey Report: Key Players are Eli Lilly and Company, Merck & Co., Inc., Amgen, Inc., Novartis AG here

News-ID: 579335 • Views: 215

More Releases from Transparency Market Research

Analysis of COVID-19 Crisis-driven Growth Opportunities in Water Pump Market- St …
The inorganic growth of businesses reduces the competition between the sector in the market for water pumps. New product growth, technological developments in products and acquisitions by worldwide conglomerates of smaller players are characteristic for the industry of water pumps. Obtain Report Details @ https://www.transparencymarketresearch.com/water-pump-market.html But tiny, unorganized players who are able to develop and market economically efficient products to serve increasing customer pools in the emerging economies also face less serious
TMR Analyzes Impact of Outbreak of COVID-19 on FPSO Equipment Market Statistics, …
The global floating production storage and offloading FPSO market is competitive and segmented. Transparency Market Research Market (TMR) report states that there are a few major players in the industry who are relentlessly developing new and innovative designs to penetrate the global market during the forecast period. Obtain Report Details @ https://www.transparencymarketresearch.com/FPSO-vessels-equipments-market.html These prominent players are focused on introducing new strategies like collaborations and partnerships to provide new in the global
Analysis of Potential Impact of COVID-19 on Medical Nutrition Market - Industry …
Medical Nutrition Market: Complementarity of Pharmacology & Nutrition to Augur Well for Growth As old health rules are overturned, a physiological approach that starts from health in place of disease is gaining high emphasis. Hippocrates quote, ‘Let food be thy medicine and medicine be thy food’ has been put into practice, as individuals are considering medical nutrition and food for enhancing health and treating disease, despite the developments procured in the
Biotech Flavors Market Valuation to reach US$ 3 Bn by 2029
According to a new study by TMR, the sales of biotech flavors are estimated to reach 134,422 metric tons in 2019. The biotech flavors market is projected to record a Y-o-Y growth of ~9% during the forecast period. Growth of the biotech flavors market remains driven by a slew of aspects, which range from increased market demand for clean label products and changing regulations in the food and beverage industry,

All 5 Releases


More Releases for Rectal

Colon and Rectal Cancer Drugs Market Opportunity Analysis, 2018 – 2026
Colon and rectal cancer are often grouped together, as they have many common features. Rate of colorectal cancer is increasing among the millennials in the U.S. The American Cancer Society (ACS) estimates that there will be around 97,220 new cases of colon cancer and around 43,030 new cases of rectal cancer registered in the U.S. in 2018. Moreover, owing to increasing risk of colorectal cancer, in May 2018, ACS updated
Rectal Cancer - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Rectal Cancer - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Rectal Cancer Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H1 2018, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large
Rectal Cancer - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Rectal Cancer - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rectal Cancer - Pipeline Review, H2 2017, provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk
Rectal Cancer-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Rectal Cancer-Pipeline Review H2 2017” this report provides an overview of the Rectal Cancer (Oncology) pipeline landscape. Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The risk factors for developing rectal cancer are increasing age, smoking, family history of colon or rectal cancer, high-fat diet and/or a diet mostly from animal sources and personal or
Rectal Cancer Market : Dynamics, Segments and Supply Demand 2016-2024
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps or colorectal
Rectal Cancer Market 2016-2024 : Technological Breakthroughs & Competitive Lands …
Rectal cancer is a malignant disease in which cancer cells form in the tissues of the rectum. The digestive system takes in nutrients from foods consumed by the host and helps waste material pass out of the body through the anus. There are various causes that contribute to the occurrence of rectal cancer such as increasing age (mostly over 50), having certain family history of rectal cancer, history of polyps